Literature DB >> 12691266

Prevention and early detection clinical trials: opportunities for primary care providers and their patients.

Leslie G Ford1, Lori M Minasian, Worta McCaskill-Stevens, Etta D Pisano, Dan Sullivan, Robert A Smith.   

Abstract

Enrollment into cancer prevention and early detection clinical trials represents a unique challenge compared with a diagnostic or treatment trial because it involves subjects without a diagnosis of cancer. This paper examines some of the barriers to participation in prevention and early detection trials and provides detailed information about two ongoing prevention and two ongoing early detection clinical trials open to enrollment as well as brief summaries of seven additional trials now open to enrollment.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12691266     DOI： 10.3322/canjclin.53.2.82

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  13 in total

Review 1.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Gabriele Dennert; Catherine M Crespi; Marcel Zwahlen; Maree Brinkman; Maurice P A Zeegers; Markus Horneber; Roberto D'Amico; Cinzia Del Giovane
Journal:  Cochrane Database Syst Rev       Date:  2014-03-30

Review 2.  Selenium for preventing cancer.

Authors:  Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Marco Vinceti; Maurice P A Zeegers; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

3.  The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials.

Authors:  Kiameesha R Evans; M Jane Lewis; Shawna V Hudson
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

4.  What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.

Authors:  W Hamilton; T J Peters; A Round; D Sharp
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

5.  The potential for using risk models in future lung cancer screening trials.

Authors:  John K Field; Olaide Y Raji
Journal:  F1000 Med Rep       Date:  2010-05-24

Review 6.  American Cancer Society lung cancer screening guidelines.

Authors:  Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2013-01-11       Impact factor: 508.702

7.  Recruiting low-income healthy women to research: an exploratory study.

Authors:  Galen Joseph; Celia P Kaplan; Rena J Pasick
Journal:  Ethn Health       Date:  2007-11       Impact factor: 2.772

Review 8.  What's new in the field of prostate cancer chemoprevention?

Authors:  Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

9.  What do people really know and think about clinical trials? A comparison of rural and urban communities in the South.

Authors:  Daniela B Friedman; Caroline D Bergeron; Caroline Foster; Andrea Tanner; Sei-Hill Kim
Journal:  J Community Health       Date:  2013-08

10.  Barriers and facilitators to recruitment to a culturally-based dietary intervention among urban Hispanic breast cancer survivors.

Authors:  Blanca Bernard-Davila; A Corina Aycinena; John Richardson; Ann Ogden Gaffney; Pam Koch; Isobel Contento; Christine Sardo Molmenti; Maria Alvarez; Dawn Hershman; Heather Greenlee
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.